Eluxadoline Bile Acid Malabsorption (BAM) Study

Clinical trial NCT03441581 · COMPLETED

Trial details

NCT number: NCT03441581
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Irritable Bowel Syndrome With Diarrhea

Start date: 2018-02-23
Primary completion: 2020-04-28
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.